Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Purpose. To assess the efficacy and safety of switching from prostaglandin analog (PGA) monotherapy to tafluprost/timolol fixed-combination (Taf/Tim) therapy. Subjects and Methods. Patients with primary open-angle glaucoma, normal-tension glaucoma, or ocular hypertension who had received PGA monothe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kazuyoshi Kitamura, Tatsuya Chiba, Fumihiko Mabuchi, Kiyotaka Ishijima, Shu Omoto, Fumiko Kashiwagi, Takashi Godo, Satoshi Kogure, Teruhiko Goto, Takashi Shibuya, Jhoji Tanabe, Shigeo Tsukahara, Tadaharu Tsuchiya, Toyoaki Tsumura, Takaharu Tokunaga, Osamu Hosaka, Tetsunori Saito, Kenji Kashiwagi
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2018/8456764
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of tafluprost and tafluprost/timolol on the thickness of the retina in the macular area
by: N. I. Kurysheva, et al.
Published: (2019-03-01)

Effect of Tafluprost and Tafloprost/Timolol on the Optic Nerve Head, Peripapillary and Macular Microcirculation According to OCT-Angiography
by: N. I. Kurysheva, et al.
Published: (2018-07-01)

Severely Circumferentially Calcified Neointima as a New Cause of Undilatable In-Stent Restenosis
by: Manabu Kashiwagi, et al.
Published: (2018-01-01)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
by: Kenji Inoue, et al.
Published: (2014-01-01)

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients
by: Wissam Georges El Hajj Moussa, et al.
Published: (2018-01-01)

Wide Variation of Squeezing Force and Dispensing Time Interval among Eyedropper Bottles
by: Kenji Kashiwagi
Published: (2019-01-01)

Timolol-induced Blepharitis and Conjunctivalization of Meibomian Glands
by: Shirali Gokharu, et al.
Published: (2025-04-01)

Experience in Application of the Combinations Dorzolamide / Timolol and Brinzolamide / Timolol for the Prevention of Intraocular Hypertension in Patients with Silicone Oil Tamponade of the Vitreal Cavity
by: A. N. Kazennov, et al.
Published: (2024-10-01)

Validation of user-friendly models predicting extracapsular extension in prostate cancer patients
by: Leandro Blas, et al.
Published: (2023-01-01)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
by: Swati Jagdale, et al.
Published: (2016-01-01)

Timolol versus latanoprost for primary open-angle glaucoma
by: Nilo Vincent dG. FlorCruz II, MD, et al.
Published: (2005-06-01)

A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
by: Curt Hartleben, et al.
Published: (2017-01-01)

Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision
by: Kenji Kashiwagi, et al.
Published: (2018-01-01)

Smallpox and Season: Reanalysis of Historical Data
by: Hiroshi Nishiura, et al.
Published: (2009-01-01)

Ship control of unberthing manoeuvring using an online estimation model under disturbance
by: Hideto Kashiwagi, et al.
Published: (2025-12-01)

Autoimmune polyglandular syndrome type 3B: a key to diagnosing autoimmune gastritis and asymptomatic primary biliary cholangitis
by: Sayaka Mabuchi, et al.
Published: (2025-05-01)

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)

Topical timolol for superficial cutaneous infantile hemangiomas in very preterm infants
by: Matić Aleksandra, et al.
Published: (2021-01-01)

Clinical Experience with Timolol and Brinzolamide Fixed-combination: A Case Series
by: S. V. Yanchenko, et al.
Published: (2025-06-01)

Topical Timolol as a Therapeutic Modality in Severe Disfiguring Infantile Haemangioma
by: Mohita Mahajan, et al.
Published: (2024-01-01)

Latanoprost/timolol fixed combination in the treatment of primary open-angle glaucoma
by: S. Yu. Petrov, et al.
Published: (2025-03-01)

Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life
by: Letizia Negri, et al.
Published: (2019-01-01)

Topical timolol for small infantile hemangioma: a new therapy option
by: Anne Weissenstein, et al.
Published: (2012-04-01)

A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients
by: Stefano Ranno, et al.
Published: (2012-01-01)

Topical Timolol in the Treatment of Hemodialysis Tunneled Catheter Exit-Site Pyogenic Granuloma
by: Renato A. Caires, et al.
Published: (2025-04-01)

Determination of related substances of travoprost in travoprost and timolol maleate eye drops by HPLC
by: LI Yujun, et al.
Published: (2025-06-01)

Transdermal delivery of timolol maleate using hydrogel microneedles for the treatment of infantile haemangiomas
by: Xiaokun Lin, et al.
Published: (2025-06-01)

Case Series Review on Use of Topical Timolol in the Treatment of Superior Oblique Myokymia
by: Victoria Alexis Smerdon, et al.
Published: (2024-12-01)

Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)

Comprehensive review of analytical techniques for evaluating fixed-dose combinations containing timolol
by: Imad O. Abu Reid, et al.
Published: (2025-05-01)

The Influence of an Information Environment on Construction Organization's Culture: A Case Study
by: Kenneth T. Sullivan, et al.
Published: (2009-01-01)

Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database
by: Masako Sakamoto, et al.
Published: (2017-01-01)

Peptide dendrimer and hyaluronic acid modified nanovesicles for ocular delivery of timolol maleate and siRNA
by: Santoshi Naik, et al.
Published: (2025-07-01)

Effectiveness and safety of hypotensive therapy of primary glaucoma with a Russian generic fixed combination of dorzolamide and timolol
by: S. Yu. Petrov, et al.
Published: (2022-09-01)

Clinical and Dermoscopic evaluation of post acne erythema after treatment with topical timolol maleate 0.5%
by: Sawen Jihanger Omer, et al.
Published: (2024-06-01)

Effect of dorzolamide compared with timolol maleate on the central corneal thickness and endothelial-cell count of glaucomatous eyes
by: Ernesto D. Golez III, MD, et al.
Published: (2007-12-01)

Factors Predicting Renal Outcomes in Hypertensive Emergencies With Severe Renal Impairment: A Single‐Center Retrospective Study
by: Rei Nakazato, et al.
Published: (2024-12-01)

Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in Japan
by: Tatsunori Murata, et al.
Published: (2020-01-01)

4,4′-methylenebis(2-chloroaniline) induces chromosome aneuploidy associated with premature chromatid separation in mammalian cells: A possible carcinogenic mechanism
by: Saho Kobayashi, et al.
Published: (2025-03-01)

Crystal structure of (μ2-7-{[bis(pyridin-2-ylmethyl)amino-1κ3N,N′,N′′]methyl}-5-chloroquinolin-8-olato-2κN;1:2κ2O)trichlorido-1κCl,2κ2Cl-dizinc(II)
by: Koji Kubono, et al.
Published: (2024-11-01)